Funding for this research was provided by:
China Scholarship Council
Technische Universität München
DFG Sonderforschungsbereich 824 (Z2, B11)
Received: 7 June 2021
Accepted: 28 July 2021
First Online: 21 August 2021
: All procedures performed in studies involving human participants were in accordance with the Declaration of Helsinki. This retrospective study has been approved by the Ethics Committee of the Technical University Munich (750/20 S-KH).
: Not applicable.
: ME reports patent application for rhPSMA and prior consulting activities for Blue Earth Diagnostics, Progenics Pharmaceuticals, Point Biopharma and Janssen Pharmaceuticals. Other authors declare that they have no competing interests.